Literature DB >> 27922231

Evaluation of central nervous system in patients with glycogen storage disease type 1a.

Yusuf Aydemir1, Figen Gürakan1, İnci Nur Saltık Temizel1, Hülya Demir1, Kader Karlı Oğuz2, Dilek Yalnızoğlu2, Meral Topçu3, Hasan Özen1, Aysel Yüce1.   

Abstract

We aimed to evaluate structure and functions of central nervous system (CNS) in children with glycogen storage disease (GSD) type 1a. Neurological examination, psychometric tests, electroencephalography (EEG), magnetic resonance imaging (MRI), visual evoked potentials (VEP) and brainstem auditory evoked potentials (BAEP) were performed. The results were compared between patients with good and poor metabolic control and healthy children. Twenty-three patients with GSD type 1a were studied. Twelve patients were in poor metabolic control group and 11 patients in good metabolic control group. Five patients had intellectual disability, 10 had EEG abnormalities, seven had abnormal VEP and two had abnormal BAEP results. MRI was abnormal in five patients. There was significant correlation between the number of hypoglycemic attacks and MRI abnormalities. Central nervous system may be affected in GSD type 1a even in patients with normal neurologic examination. Accumulation of abnormal results in patients with poor metabolic control supports the importance of metabolic control in GSD type 1a.

Entities:  

Keywords:  central nervous system; glycogen storage disease type 1a; hypoglycemia; intellectual disability

Mesh:

Year:  2016        PMID: 27922231     DOI: 10.24953/turkjped.2016.01.002

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  2 in total

1.  Glycogen storage disease type 1a in the Ohio Amish.

Authors:  Ethan M Scott; Olivia K Wenger; Elizabeth Robinson; Kristina Colling; Miraides F Brown; Jennifer Hershberger; Kadakkal Radhakrishnan
Journal:  JIMD Rep       Date:  2022-06-21

2.  Neurological Characteristics of Pediatric Glycogen Storage Disease.

Authors:  Julio Henrique Muzetti; Daniel Almeida do Valle; Mara L S Ferreira Santos; Bruno Augusto Telles; Mara L Cordeiro
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-21       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.